Wyeth-Lederle Vaccines clinical trials
Acquired by Pfizer, Oct 15, 2009 · source ↗
The registry lists 2 studies whose lead sponsor is Wyeth-Lederle Vaccines. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 24, 2005.
- 2studies on the registry
- 0open to participants now
Before and after it joined Pfizer
- First submitted before Wyeth-Lederle Vaccines became part of Pfizer
- 2
- First submitted after Wyeth-Lederle Vaccines became part of Pfizer
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Wyeth-Lederle Vaccines’ studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.
Studies, none open
- 0 open · 2
All 2 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed2100%
Registry sponsor names on this page
- Wyeth-Lederle Vaccines2 studies
Something wrong with this grouping? Tell us on the Pfizer page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Pfizer studies →
- Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative VolunteersCompletedNCT00002231Phase 1
Sponsor listed in the registry: Wyeth-Lederle Vaccines · First submitted before Wyeth-Lederle Vaccines became part of Pfizer
- A Study of GENEVAX-HIV, a Possible VaccineCompletedNCT00002232Phase 1
Sponsor listed in the registry: Wyeth-Lederle Vaccines · First submitted before Wyeth-Lederle Vaccines became part of Pfizer